$3M Pre-Seedlaunch video

Cellbyte

Backed byFrontline Ventures

About Cellbyte

Cellbyte is building an AI-native platform to help pharma companies launch new drugs worldwide. The company empowers pharma commercial teams to cut through complexity, analyze previously fragmented data in seconds, and automate high-stakes workflows. It builds AI agents for pharmaceutical drug launches and automates repetitive workflows on a robust data foundation, helping bring life-changing treatments to patients faster. Backed by Y-Combinator, Cellbyte positions itself as an AI-native platform for pharma drug launches.

Open positions

Company at a glance

IndustryHealthTech
Team Size1-10
StageSeed
Founded2024
Locations
Munich, Germany ·Germany
Investors
Frontline Ventures ·Pace Ventures ·Saras Capital ·Springboard Health Angels ·Y Combinator
LinkedInLinkedIn

About the Team

Team Distribution

  • Leadership40%
  • Engineering40%
  • Operations20%

Where the Team Studied

  1. 1.Technical University of Munich
  2. 2.Ludwig-Maximilians-Universität München
  3. 3.Freie Universität Berlin
  4. 4.Durham University
  5. 5.RWTH Aachen University

Team Worked At

  • Kinapse
  • Celonis
  • BCG
  • Siemens
  • appliedAI Initiative GmbH

Funding History

SeedNov 2025

$2.8M

raised

AI drug-launch platform Cellbyte raised a $2.75 million seed round led by Frontline Ventures with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels.

Frontline VenturesY CombinatorSpringboard Health AngelsSaras CapitalPace Ventures

Life at Cellbyte

Frequently asked questions